Adjudicating Heart Failure as an End Point in Dialysis Trials: More Signal, Less Noise
American Journal of Nephrology · 25.06.2026 · 1-5
DOI: 10.1159/000553102 ↗Kurz gefasst
Kommentar in der Zeitschrift American Journal of Nephrology, online erschienen am 25.06.2026. Verfasst von Emma O Apos Lone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- University of Sydney, Camperdown, Sydney, New South Wales, Australia.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK, patrick.mark@glasgow.ac.uk.
- Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK, patrick.mark@glasgow.ac.uk.
Zitieren
APA
O Apos Lone, E., & Mark, P. B. (2026). Adjudicating Heart Failure as an End Point in Dialysis Trials: More Signal, Less Noise. American Journal of Nephrology, 1-5. https://doi.org/10.1159/000553102
Vancouver
O Apos Lone E, Mark PB. Adjudicating Heart Failure as an End Point in Dialysis Trials: More Signal, Less Noise. American Journal of Nephrology. 2026:1-5. doi:10.1159/000553102
BibTeX
@article{OAposLone2026,
author = {O Apos Lone, Emma and Mark, Patrick B},
title = {Adjudicating Heart Failure as an End Point in Dialysis Trials: More Signal, Less Noise},
journal = {American Journal of Nephrology},
year = {2026},
pages = {1--5},
doi = {10.1159/000553102}
}
EUVIMED